Results 101 to 110 of about 29,502 (239)
Framework for 3D TransRectal Ultrasound [PDF]
Prostate biopsies are mainly performed under 2D TransRectal UltraSound (TRUS) control by sampling the prostate according to a predefined pattern. In case of first biopsies, this pattern follows a random systematic plan. Sometimes, repeat biopsies can be needed to target regions unsampled by previous biopsies or resample critical regions (for example in
arxiv
Human Pappilomavirus Genotype in Cervical Tissue of Patients with Cervical Intraepithelial Neoplasia (CIN) 1, CIN 2, and CIN 3 [PDF]
Objectives: to determine the genotype of HPV in patients with precancerous lesions of cervical tissue.Materials and Methods: An observational study with cross sectional study of patients paraffin block CIN1, CIN2, CIN3 was conducted in Dr Soetomo ...
Alia, R. (Rahmi)+4 more
core +1 more source
ABSTRACT Objective Determine the feasibility of high‐risk human papillomavirus (HPV)‐based cervical screening that included the option of a vaginal swab HPV test (vaginal self‐test). Design Implementation trial. Setting 17 primary care practices. Population or Sample People due for a cervical screening test.
Peter Sykes+12 more
wiley +1 more source
The role of immunohistochemical research at the diagnosis of neoplastic lesions of the cervix [PDF]
The analysis of literature data about the use of immunohistochemical markers for the diagnosis and differential diagnosis of cervical lesions. The most significant assistance in identifying and determining the degree of cervical intraepithelial neoplasia
A I Shchegolev, O D Mishnev
doaj
Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay [PDF]
Background and objective: The VALGENT framework is developed to assess the clinical performance of HPV tests that offer genotyping capability. Samples from the VALGENT-3 panel are used to identify an optimal viral concentration threshold for the RIATOL ...
Arbyn, Marc+6 more
core +1 more source
Surgical removal of cervical tissue at age 60–64 identifies occult lesions, but does not eradicate HPV infections in almost half of the women. This information can help inform women and doctors before undertaking such procedures. Abstract Introduction For women treated for cervical dysplasia at 60–64 years in Denmark, we reported the frequency of ...
Julie Laub Erdal+3 more
wiley +1 more source
Cervical intraepithelial neoplasia.
J. D. Wilson, A. J. Robinson, J. Tullett
+10 more sources
How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa [PDF]
Despite ongoing efforts, sub-Saharan Africa faces a higher cervical cancer burden than anywhere else in the world. Besides HPV infection, definitive factors of cervical cancer are still unclear.
Angeletti, Peter C.+5 more
core +1 more source
Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland [PDF]
In Scotland, a national HPV immunisation programme began in 2008 for 12-13 year olds, with a catch-up campaign from 2008-2011 for those under the age of 18.
A Potts+31 more
core +3 more sources
In a real‐world setting, one‐fifth of long‐term screening non‐attending women 29–64 years of age, who previously had received many invitations and interventions for cervical screening, responded to a vaginal HPV self‐sampling offer. Biopsied women positive for HPV16 or HPV18 had a high prevalence of HSIL or cervical cancer, which strongly supports ...
Avalon Sundqvist+4 more
wiley +1 more source